Dr. Daniel Taheri, MD

Dr. Taheri practices at Westwood Surgery Center in Los Angeles, California.

Dr. Taheri's NPI, 1992774681, was assigned on March 15, 2006. Dr. Taheri graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Taheri holds California license G80445.

Dr. Taheri's primary practice is Westwood Surgery Center, at 10884 Santa Monica Boulevard, Suite #202, Los Angeles, CA 90025. The practice phone is (310) 446-4647.

Dr. Taheri's primary practice is Westwood Surgery Center in Los Angeles, California. The medical group on file is Skin and Cancer Institute. Dmand AI also links Dr. Taheri to 4 more group practices and clinics, 4 medical groups, 2 physician offices and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taheri practices, 8 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Taheri's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Taheri is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Taheri's licenses on file in 8 states: California, Arizona, Alaska, Texas, Utah, New Mexico, Nevada and Wyoming.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and minor head injury among the conditions Dr. Taheri treats.

CMS data shows 48,018 Medicare services from Dr. Taheri across 44 procedure codes in 2024, for 1,622 Medicare patients. Medicare paid $9,883,049 for them.

CMS counts 1,622 Medicare patients who saw Dr. Taheri in 2024. The largest group is 65 to 74, with 784 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Taheri's median patient age at 51, with 59% women.

In 2024, Dr. Taheri wrote 478 Medicare Part D claims for 172 patients. 80% of them were for generic drugs. CMS names the drug for 321 of them, across 12 drugs with 11 or more claims each, at $102,876 in total drug cost. In 2023, CMS named 590 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Taheri for performance year 2024, reported as part of a group. Dr. Taheri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 512 procedures of skin biopsy by Dr. Taheri, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 233 general payments to Dr. Taheri from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Sun Pharmaceutical Industries Inc. paid the most, $9,761.

Dmand AI lists 2 awards for Dr. Taheri, most recently CMS Stage 1 EHR in 2013.

Dr. Taheri graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Taheri is a member of AAD.

Dr. Taheri is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.